Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies
Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies
Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
All Stories

Technology

1337 articles · sorted by newest first

AllAI & SocietyBig Tech & MarketsScience & SpaceCyber & Privacy

Latest in Technology

Latest in Technology
20 results
Technology 6/17/2026

The Webb telescope has captured its first 'bulge fossil fragment'

The James Webb Space Telescope, in a groundbreaking collaboration with the Hubble Space Telescope, has identified a celestial body previously misclassified as a globular star cluster: Terzan 5 has been revealed as a 'bulge fossil fragment,' offering unprecedented insight into the violent, chaotic birth of galactic bulges and, by extension, our own Milky Way galaxy. This reclassification, announced by researchers on June 16, 2026, overturns decades of astronomical understanding and provides direct observational evidence for how the central, densely packed regions of galaxies form.

Editorial Team1 min
The Webb telescope has captured its first 'bulge fossil fragment'
Technology 6/17/2026

NJ Alzheimer's Town Hall: Why Clinical Trials May Hold the Key to a Cure

The recent Alzheimer's Research and Awareness Town Hall in Tenafly, NJ, underscored a critical pivot in the battle against neurodegeneration: clinical trials are no longer just a distant hope, but the immediate frontier for impactful therapeutic breakthroughs. This shift comes amidst a flurry of recent scientific advancements, from novel drug targets to the expanded use of existing treatments, signaling a dynamic new era for millions grappling with the disease. The Kaplen JCC on the Palisades hosted experts who highlighted that while challenges remain, the pace of discovery is accelerating, moving beyond historical frustrations to a more diversified and targeted approach to treatment and prevention.

Editorial Team1 min
NJ Alzheimer's Town Hall: Why Clinical Trials May Hold the Key to a Cure
Technology 6/16/2026

Tesla Cybercab specs reveal low weight, big range

Tesla's highly anticipated Cybercab, its dedicated robo-taxi, has revealed its official EPA specifications, signaling a significant step towards commercial deployment. Documents certify a curb weight of 3,113 lbs, a 219 HP front-wheel-drive motor, and a 48 kWh lithium-ion battery, promising an EPA-adjusted range of approximately 293 miles. This filing comes as Tesla ramps up production at Gigafactory Texas, albeit without full regulatory approval for unsupervised autonomous operation.

Editorial Team1 min
Tesla Cybercab specs reveal low weight, big range
Technology 6/16/2026

Microsoft reportedly negotiating closures of multiple Xbox studios, including Psychonauts' Double Fine, South of Midnight's Compulsion and Hellblade's Ninja Theory - Eurogamer

Microsoft's Xbox division is reportedly in active negotiations to close or divest multiple esteemed game development studios, including Double Fine, Compulsion Games, and Ninja Theory, sending shockwaves through the gaming industry. The news, corroborated by multiple reports, suggests these studios, behind titles like 'Psychonauts', 'South of Midnight', and the 'Hellblade' series, are scrambling to negotiate independence to avert outright shutdowns. This sweeping reorganization signals a brutal new phase in Xbox's strategy, driven by a directive from new CEO Asha Sharma to curb plunging revenues and shrinking margins.

Editorial Team1 min
Microsoft reportedly negotiating closures of multiple Xbox studios, including Psychonauts' Double Fine, South of Midnight's Compulsion and Hellblade's Ninja Theory - Eurogamer
Technology 6/16/2026

Celldex presents long─term results from Phase II study of barzolvolimab

Celldex Therapeutics has unveiled groundbreaking long-term results from its Phase 2 study of barzolvolimab, revealing sustained and profound improvements in angioedema for patients suffering from chronic spontaneous urticaria (CSU) that is refractory to standard antihistamines. Presented at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Meeting in Istanbul this past week, the data showed up to 64% of angioedema-afflicted patients remained symptom-free seven months after discontinuing treatment, signaling a potential paradigm shift from mere symptom control to genuine disease modification.

Editorial Team1 min
Celldex presents long─term results from Phase II study of barzolvolimab
Technology 6/16/2026

Have a thorny medical question? Your doctor may be using AI for that

A groundbreaking new study published in Nature Medicine on June 12, 2026, reveals that general-purpose large language models (LLMs) like Google's Gemini and OpenAI's ChatGPT are outperforming specialized clinical AI tools, including the rapidly adopted OpenEvidence, across key medical benchmarks. This finding challenges the industry's belief in purpose-built AI, as OpenEvidence, a startup now valued at $12 billion, has seen its physician-led adoption surge to over half of U.S. doctors, who used it for 30 million consultations last month alone. The platform offers instant, evidence-based answers to 'thorny medical questions,' with Dr. Nicholas Gavin, Mount Sinai's Chief Clinical Innovation Officer, confirming its widespread, often 'shadow AI' use among his colleagues.

Editorial Team1 min
Have a thorny medical question? Your doctor may be using AI for that
Technology 6/16/2026

Giant Nevada Project Could Transform Astronomy

Caltech has officially greenlit the construction of the Deep Synoptic Array (DSA) in Nevada, a groundbreaking $200 million radio telescope project poised to revolutionize humanity's ability to observe the universe. With its final design review successfully completed this month and full funding from Schmidt Sciences, the DSA will deploy an unprecedented 1,650 dishes across 120 square miles, transforming radio astronomy from static images to a real-time 'radio camera' of the cosmos.

Editorial Team1 min
Giant Nevada Project Could Transform Astronomy
Technology 6/16/2026

Qualcomm CEO says AI agents will replace apps — as chip giant works on 40 new AI-powered devices

Qualcomm CEO Cristiano Amon has ignited a new front in the AI wars, declaring that 'AI agents will be the new app' and smart glasses are poised to eclipse the smartphone as the dominant personal computing device. This bold assertion comes as the chipmaking titan unveils its latest, most powerful silicon, the Snapdragon Reality Elite, and confirms it's actively developing over 40 new AI-powered devices, ranging from camera-equipped earbuds to smart jewelry, all designed to facilitate an agent-centric digital future. The strategic shift signals a fundamental reimagining of human-technology interaction, moving beyond a siloed app ecosystem towards intelligent, context-aware assistants that operate across a distributed network of wearables.

Editorial Team1 min
Qualcomm CEO says AI agents will replace apps — as chip giant works on 40 new AI-powered devices
Technology 6/16/2026

What Canadian health IT buyers want before they sign

A new survey of 212 Canadian healthcare IT leaders reveals a seismic shift in procurement demands, with buyers now requiring concrete proof from vendors on critical fronts: strict interoperability, robust Canadian data sovereignty, explicit AI governance, and clear workflow return on investment. Forget broad promises; 96% of Canadian healthcare IT buyers mandate or heavily weight interoperability in upcoming RFPs, and 74% prohibit the use of Canadian protected health information for AI training without explicit written consent.

Editorial Team1 min
What Canadian health IT buyers want before they sign
Technology 6/16/2026

In vivo CRISPR therapy successfully reduces hereditary angioedema attacks in first Phase III trial

Intellia Therapeutics has announced groundbreaking Phase III results for lonvoguran ziclumeran (NTLA-2002), its in vivo CRISPR gene editing therapy for hereditary angioedema (HAE), marking the first successful late-stage trial of an in vivo CRISPR treatment. The HAELO trial demonstrated an 87% relative reduction in monthly HAE attacks compared to placebo, with 62% of treated patients remaining attack-free without ongoing prophylactic medication. This achievement, detailed by researchers from Amsterdam UMC and published in The New England Journal of Medicine, signals a potential paradigm shift toward single-dose, curative genetic interventions for a debilitating chronic condition.

Editorial Team1 min
In vivo CRISPR therapy successfully reduces hereditary angioedema attacks in first Phase III trial
Technology 6/16/2026

Your cheat sheet to Anthropic's latest drama with the White House

In an unprecedented move, the Trump administration's Commerce Department has forced AI powerhouse Anthropic to abruptly disable its newly launched, most advanced AI models, Fable 5 and Mythos 5, for all global users after issuing an Export Control Directive on June 12, 2026. Citing nebulous 'National Security Concerns' over a potential 'AI Jailbreak' in Fable 5 that could exploit software vulnerabilities, the directive marks a significant escalation from previous hardware restrictions to directly controlling deployed commercial AI models. This shock intervention comes as Anthropic was reportedly preparing for a nearly $1 trillion IPO, sending ripples of uncertainty through the burgeoning AI market.

Editorial Team1 min
Your cheat sheet to Anthropic's latest drama with the White House
Technology 6/15/2026

Anthropic export ban exposes Europe's AI sovereignty gap

The Trump administration has triggered a global scramble over AI governance, ordering Anthropic to restrict access to its cutting-edge Fable 5 and Mythos 5 AI models for all foreign nationals after Amazon researchers allegedly uncovered a critical vulnerability. This unprecedented export control directive, issued by U.S. Commerce Secretary Howard Lutnick on Friday, June 12, 2026, forced Anthropic to abruptly disable both models worldwide, exposing Europe's stark reliance on American-controlled frontier AI.

Editorial Team1 min
Anthropic export ban exposes Europe's AI sovereignty gap
Technology 6/15/2026

Early AI Vaccine Trial Could Reshape How Australia Plans for Future Outbreaks - eWeek

In a breakthrough that could fundamentally reshape global pandemic preparedness, an AI-designed universal coronavirus vaccine has successfully completed its first human safety trial, marking a historic milestone in vaccinology. The experimental vaccine, known as pEVAC-PS, was developed by the University of Cambridge and its spin-out DIOSynVax, demonstrating that an active vaccine component created entirely through computer simulations is safe for human use. This pioneering achievement signals a new era where artificial intelligence moves from research support to actively designing biological components for human trials, with Australia closely watching its implications for future outbreak strategies.

Editorial Team1 min
Early AI Vaccine Trial Could Reshape How Australia Plans for Future Outbreaks - eWeek
Technology 6/15/2026

'The paradox of the death gene': Stress defense mechanism that saves brain cells revealed

Scientists at the Daegu Gyeongbuk Institute of Science and Technology (DGIST) have uncovered a groundbreaking paradox: the p53 gene, universally known as the 'death gene' for its tumor-suppressing role, actually acts as a protective shield for brain cells under chronic stress. This pivotal research, led by Professor Yu Seong-woon and published in the journal Autophagy, reveals that p53 prevents the demise of hippocampal neural stem cells by inhibiting autophagic cell death, potentially unlocking a radically new approach to treating stress-related brain disorders.

Editorial Team1 min
'The paradox of the death gene': Stress defense mechanism that saves brain cells revealed
Technology 6/15/2026

Indian AI startups confront new risks after Anthropic pulls Fable 5

Anthropic, a leading US-based AI developer, abruptly withdrew access to its advanced models, Fable 5 and Mythos 5, for foreign nationals on June 12, 2026, following a direct order from the US government citing national security concerns. This unprecedented move, the first known instance of AI models being subjected to export controls, has sent shockwaves through India's burgeoning AI ecosystem, exposing the deep vulnerabilities of Indian startups heavily reliant on foreign foundational models.

Editorial Team1 min
Indian AI startups confront new risks after Anthropic pulls Fable 5
Technology 6/15/2026

Jio Platforms in global top20 of WIPO patent alliance list

Jio Platforms, the tech arm of Indian conglomerate Reliance Industries, has made a remarkable leap into the global top 20 of the World Intellectual Property Organisation's (WIPO) Patent Cooperation Treaty (PCT) rankings for 2025, positioning itself alongside established global tech giants like Huawei, Samsung, and Google. This unprecedented ascent of 320 places marks the first time an Indian company has achieved such a prominent standing in international patenting, signaling a critical pivot in India's innovation narrative.

Editorial Team1 min
Jio Platforms in global top20 of WIPO patent alliance list
Technology 6/15/2026

Satya Nadella warns AI could leave entire industries struggling if value stays with few companies - India Today

Microsoft CEO Satya Nadella has issued a stark warning that unchecked Artificial Intelligence could concentrate economic value among a handful of powerful foundation models, threatening to 'hollow out' entire industries and destabilize the political economy. In a detailed post titled 'A Frontier Without an Ecosystem Is Not Stable,' Nadella argues this mirrors the displacement seen during early globalization, where aggregate economic growth masked severe industry-specific job losses and expertise erosion. His intervention sharpens a growing debate over AI's true societal cost if its benefits are not broadly distributed.

Editorial Team1 min
Satya Nadella warns AI could leave entire industries struggling if value stays with few companies - India Today
Technology 6/15/2026

Chip woes stretch planning cycles: Ericsson India MD Nitin Bansal

Ericsson India, a key player in global telecom infrastructure, is drastically extending its operational planning horizons from the standard 18-36 months to an unprecedented three to five years. This strategic pivot, revealed by MD Nitin Bansal on June 14, 2026, is a direct response to persistent semiconductor shortages, exponentially rising component costs, and broad supply chain uncertainties exacerbated by geopolitical factors, including the West Asian conflict. The move underscores a profound shift in how major tech firms are navigating a volatile global manufacturing landscape, with long-term forecasting becoming paramount to ensure continuity.

Editorial Team1 min
Chip woes stretch planning cycles: Ericsson India MD Nitin Bansal
Technology 6/15/2026

Exercise decreases among people taking GLP-1 medication - FirstWord Pharma

A groundbreaking study presented at ENDO 2026 reveals a critical and unexpected side effect of GLP-1 medications: individuals taking these highly popular weight-loss drugs are significantly decreasing their physical activity levels. Utilizing real-world Fitbit data from the National Institutes of Health's All of Us Research Program, researchers found a measurable decline in daily step counts and moderate-to-vigorous physical activity, challenging the assumption that weight loss naturally leads to increased movement. This paradox presents a significant concern for long-term health outcomes, particularly the preservation of lean muscle mass.

Editorial Team1 min
Exercise decreases among people taking GLP-1 medication - FirstWord Pharma
Technology 6/14/2026

Tuberculosis may spread before people realize they are sick, a new study warns

A groundbreaking study published in Nature Communications on June 5, 2026, has upended long-held assumptions about tuberculosis transmission, revealing that asymptomatic individuals are significant drivers of its spread. Researchers Chen, Hu, and Horsburgh found that between 25.0% and 51.3% of new Mycobacterium tuberculosis (Mtb) infections in eastern China originated from patients showing no overt symptoms. This finding directly challenges traditional public health strategies that primarily focus on symptomatic, coughing individuals as the main source of contagion.

Editorial Team1 min
Tuberculosis may spread before people realize they are sick, a new study warns
‹ Prev1…4950515253…67Next ›

Page 51 of 67 · 1337 articles

ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies